Related references
Note: Only part of the references are listed.Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
James Devaney et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells
Regina Mayor et al.
EPIGENETICS (2011)
HYAL1 overexpression is correlated with the malignant behavior of human breast cancer
Jin-Xiang Tan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
Vera N. Senchenko et al.
BMC CANCER (2010)
Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis
Mark E. Reeves et al.
BMC CANCER (2010)
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer
Raj Chari et al.
BMC SYSTEMS BIOLOGY (2010)
Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer
Raj Chari et al.
CANCER AND METASTASIS REVIEWS (2010)
5-azacytidine treatment reorganizes genomic histone modification patterns
Vitalina M. Komashko et al.
Epigenetics (2010)
Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping
Pei-Yin Hsu et al.
GENOME RESEARCH (2010)
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Antje M. Richter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
R. Mayor et al.
BRITISH JOURNAL OF CANCER (2009)
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
Amy M. Dworkin et al.
SEMINARS IN CANCER BIOLOGY (2009)
Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
Yutaka Kondo
YONSEI MEDICAL JOURNAL (2009)
Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor
Anthony R. Dallosso et al.
PLOS GENETICS (2009)
Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer
Petr Novak et al.
CANCER RESEARCH (2008)
Epigenetic Regulation of HYAL-1 Hyaluronidase Expression IDENTIFICATION OF HYAL-1 PROMOTER
Vinata B. Lokeshwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer
Pawel Karpinski et al.
MOLECULAR CANCER RESEARCH (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hyalurondiase: Both a tumor promoter and suppressor
Vinata B. Lokeshwar et al.
SEMINARS IN CANCER BIOLOGY (2008)
Evaluation of the 3p21.3 tumour-suppressor gene cluster
L. B. Hesson et al.
ONCOGENE (2007)
Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer
Megan P. Hitchins et al.
CANCER RESEARCH (2007)
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis
Susan J. Clark
HUMAN MOLECULAR GENETICS (2007)
Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias
Hung-Cheng Lai et al.
GYNECOLOGIC ONCOLOGY (2007)
RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of β-catenin by interacting with βTrCP
Emilie Estrabaud et al.
CANCER RESEARCH (2007)
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
Louise van der Weyden et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Regional copy number-independent deregulation of transcription in cancer
Nicolas Stransky et al.
NATURE GENETICS (2006)
Epigenetic inactivation of the HOXA gene cluster in breast cancer
Petr Novak et al.
CANCER RESEARCH (2006)
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band
J Frigola et al.
NATURE GENETICS (2006)
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
L Udabage et al.
EXPERIMENTAL CELL RESEARCH (2005)
Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer
M Ito et al.
CANCER LETTERS (2005)
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas
L Hesson et al.
ONCOGENE (2004)
RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma
LSN Chow et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity
GL Carboni et al.
ONCOGENE (2003)
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features
A Martinez et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss
A Maitra et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
